NCT07501858 is a clinical trial in Metabolic Syndrome, sponsored by Center of New Medical Technologies.

Who is sponsoring NCT07501858?

NCT07501858 is sponsored by Center of New Medical Technologies.

What condition does NCT07501858 study?

NCT07501858 studies Metabolic Syndrome.

Is NCT07501858 still recruiting?

NCT07501858 is currently recruiting now. Last updated 30 March 2026.

Last reviewed 2026-03-30 · How we verify

NCT07501858

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessing the Association Between H. Pylori Persistence and the Severity of Insulin Resistance in Patients With Metabolic Syndrome

Recruiting now Last updated 30 March 2026

What this trial tests

trial in Metabolic Syndrome in 100 participants. Currently enrolling.

Timeline

1 April 2026

Primary endpoint
1 April 2028

1 July 2028

Quick facts

Lead sponsor	Center of New Medical Technologies
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	100
Start date	1 April 2026
Primary completion	1 April 2028
Estimated completion	1 July 2028
Sites	1 location across Russia

Conditions studied

Metabolic Syndrome — all drugs for Metabolic Syndrome →

Sponsor

Center of New Medical Technologies

Who can join

Adults 18 to 65, any sex, with Metabolic Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This retrospective cohort study evaluates the association between H. pylori persistence and insulin resistance severity (HOMA-IR) in 100 patients with metabolic syndrome at Novosibirsk's Center for New Medical Technologies (CNMT). Patients are divided into infected (n=50) and non-infected (n=50) groups, assessing metabolic parameters, gastro panel, and CRP. Primary endpoint: HOMA-IR differences; secondary: correlations with gastric inflammation and metabolic markers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Metabolic Syndrome

Currently open trials in the same condition.

NCT06857929 — "Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition" · NA · recruiting
NCT07237750 — iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss · NA · recruiting
NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
NCT07383220 — Effect of Electrical Stimulation and Exercise on Blood Flow in Patients With Resistant High Blood Pressure · NA · recruiting
NCT07430839 — Exercise and Carotid Artery Function in Metabolic Syndrome · recruiting

Other Center of New Medical Technologies trials

Trials by the same sponsor.

NCT06357936 — Nanofat Grafting as a Method of Treating Critical Limb Ischemia · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07501858 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Center of New Medical Technologies
Last refreshed: 30 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07501858.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing